E-LIB Suche - Ergebnisse für: Bouchaab, H.

1

195MO Tarlatamab in previously treated small cell lung canc..:

Hummel, H-D. ; Champiat, S. ; Garcia, M.E. Olmedo...
ESMO Open. 9 (2024) - p. 102768 , 2024

Link: https://doi.org/10.1016/..

2

254TiP A phase I clinical trial testing the dose escalation..:

Perentes, J.Y. ; Chriqui, L-E. ; Bouchaab, H....
ESMO Open. 9 (2024) - p. 102716 , 2024

Link: https://doi.org/10.1016/..

3

Outcomes of Stage IIIa and Well-Selected Stage IIIb or Olig..:

Forster, C ; Abdelnour-Berchtold, E ; Chriqui, L E...
British Journal of Surgery. 110 (2023) Supplement_5 - p. , 2023

Link: https://doi.org/10.1093/..

4

Lung stereotactic radiation therapy: Intercomparison of irr..:

Le Reun, E. ; Casutt, A. ; Durham, A....
Cancer/Radiothérapie. 27 (2023) 1 - p. 31-41 , 2023

Link: https://doi.org/10.1016/..

5

125P A phase IIa study of the novel immunogenic cell death ..:

Imbimbo, M. ; Ghisoni, E. ; Mulvey, A....
Immuno-Oncology and Technology. 16 (2022) - p. 100237 , 2022

Link: https://doi.org/10.1016/..

6

Systematic comparison with autoimmune liver disease identif..:

Coukos, A ; Vionnet, J ; Obeid, M...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jitc-2022-005635. , 2022

Link: https://serval.unil.ch/n..

7

Humoral Responses Against Variants of Concern by COVID-19 m..:

Obeid, M ; Suffiotti, M ; Pellaton, C...
info:eu-repo/semantics/altIdentifier/doi/10.1001/jamaoncol.2022.0446. , 2022

Link: https://serval.unil.ch/n..

8

A differential process mining analysis of COVID-19 manageme..:

Cuendet M. A ; Gatta R ; Wicky A...
info:eu-repo/semantics/altIdentifier/pmid/36568192. , 2022

Link: https://hdl.handle.net/1..

9

Verzögerte Diagnose eines Lungenkarzinoms, das sich als cho..:

Haeller, C.N ; Khamsy, L ; Kloepper, J...
info:eu-repo/semantics/altIdentifier/doi/10.1055/a-1771-6452. , 2022

Link: https://serval.unil.ch/n..

10

A differential process mining analysis of COVID-19 manageme..:

Cuendet, M.A ; Gatta, R ; Wicky, A...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2022.1043675. , 2022

Link: https://serval.unil.ch/n..

11

Thérapies ciblées et carcinomes non à petites cellules : no..:

Stauber, R ; Gro S, L ; Nguyen-Ngoc, T...
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2022.18.782.970. , 2022

Link: https://serval.unil.ch/n..

12

Oncologie [2021 Oncology update]:

Meyer, M.L ; Chrysou, K ; Stamatiou, A...
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2022.18.767.182. , 2022

Link: https://serval.unil.ch/n..

13

Late-onset and long-lasting immune-related adverse events f..:

Ghisoni, E. ; Wicky, A. ; Bouchaab, H....
European Journal of Cancer. 149 (2021) - p. 153-164 , 2021

Link: https://doi.org/10.1016/..

14

68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-r..:

Boughdad, S ; Latifyan, S ; Fenwick, C...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jitc-2021-003594. , 2021

Link: https://serval.unil.ch/n..

15

Is sleeve lobectomy safe after induction therapy?-a systema..:

Chriqui, L.E ; Forster, C ; Lovis, A...
info:eu-repo/semantics/altIdentifier/doi/10.21037/jtd-21-939. , 2021

Link: https://serval.unil.ch/n..